Overview

Implementing LISA Surfactant in Nigeria

Status:
Not yet recruiting

Trial end date:
2024-05-31

Target enrollment:

Participant gender:

Summary

Implement Less Invasive Surfactant Administration in six tertiary institutions in Nigeria and evaluate its impact on 72-hour neonatal mortality in premature infants born less than 2000 grams at birth.

Phase:

Phase 4

Details

Lead Sponsor:

Indiana University

Collaborator:

BLES Pharmaceuticals

Treatments:

Pulmonary Surfactants